NASDAQ:FBLG FibroBiologics (FBLG) Stock Price, News & Analysis $2.09 +0.23 (+12.37%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$1.80▼$2.2850-Day Range$1.11▼$5.3952-Week Range$1.08▼$55.00Volume501,200 shsAverage Volume191,480 shsMarket Capitalization$74.65 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get FibroBiologics alerts: Email Address FibroBiologics MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy4.15% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.89Based on 6 Articles This WeekInsider TradingAcquiring Shares$35,235 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.37) to ($0.29) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.60 out of 5 starsMedical Sector840th out of 910 stocksPharmaceutical Preparations Industry392nd out of 426 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for FibroBiologics.Read more about FibroBiologics' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.15% of the float of FibroBiologics has been sold short.Short Interest Ratio / Days to CoverFibroBiologics has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in FibroBiologics has recently increased by 78.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldFibroBiologics does not currently pay a dividend.Dividend GrowthFibroBiologics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FBLG. Previous Next 3.3 News and Social Media Coverage News SentimentFibroBiologics has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for FibroBiologics this week, compared to 1 article on an average week.Search Interest2 people have searched for FBLG on MarketBeat in the last 30 days. MarketBeat FollowsOnly 4 people have added FibroBiologics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, FibroBiologics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $35,235.00 in company stock and sold $0.00 in company stock.Read more about FibroBiologics' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for FibroBiologics are expected to grow in the coming year, from ($0.37) to ($0.29) per share.Read more about FibroBiologics' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…Go here now to watch my new documentary About FibroBiologics Stock (NASDAQ:FBLG)FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.Read More FBLG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FBLG Stock News HeadlinesAugust 13, 2024 | insidertrades.comFibroBiologics, Inc. (NASDAQ:FBLG) CEO Purchases $16,235.00 in StockAugust 13, 2024 | insidertrades.comFibroBiologics, Inc. (NASDAQ:FBLG) Insider Hamid Khoja Acquires 10,000 SharesSeptember 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…September 7 at 2:53 AM | americanbankingnews.comFibroBiologics (NASDAQ:FBLG) Upgraded at EF Hutton Acquisition Co. ISeptember 6 at 9:31 AM | globenewswire.comFibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 5 at 4:48 PM | msn.comEF Hutton Initiates Coverage of FibroBiologics (FBLG) with Buy RecommendationAugust 20, 2024 | globenewswire.comFibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based TechnologyAugust 15, 2024 | finance.yahoo.comFBLG: Proof-of-Concept Data for Artificial Thymus Technology…September 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…August 7, 2024 | globenewswire.comFibroBiologics Files 2024 Second Quarter ReportJuly 15, 2024 | globenewswire.comFibroBiologics to Present at JonesTrading Healthcare Summit 2024June 25, 2024 | globenewswire.comFibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid TechnologyJune 13, 2024 | globenewswire.comFibroBiologics Set to Join Russell 2000® IndexJune 6, 2024 | globenewswire.comFibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024May 15, 2024 | globenewswire.comFibroBiologics Announces 2024 Annual Meeting of StockholdersMay 15, 2024 | msn.comFBLG Stock Earnings: FibroBiologics, Inc. – Common Stock Reported Results for Q1 2024May 14, 2024 | globenewswire.comFibroBiologics Files 2024 First Quarter ReportMay 7, 2024 | globenewswire.comFibroBiologics to Present at the BIO International Convention 2024See More Headlines Receive FBLG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FibroBiologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/07/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:FBLG Previous SymbolNASDAQ:FBLG CUSIPN/A CIK1958777 Webwww.fibrobiologics.com Phone281-671-5150FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.64 Quick Ratio0.64 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-29.86Miscellaneous Outstanding Shares35,719,000Free FloatN/AMarket Cap$74.65 million OptionableN/A BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Peter O'Heeron (Age 60)Founder, Chairman & CEO Comp: $950.72kMr. Mark C. Andersen C.F.A. (Age 52)CPA, M.B.A., Chief Financial Officer Comp: $461.88kDr. Hamid Khoja Ph.D. (Age 54)Chief Scientific Officer Comp: $423.12kMr. Ruben A. GarciaGeneral CounselKey CompetitorsInhibrxNASDAQ:INBXZentalis PharmaceuticalsNASDAQ:ZNTL2seventy bioNASDAQ:TSVTADC TherapeuticsNYSE:ADCTImmutepNASDAQ:IMMPView All CompetitorsInsiders & InstitutionsMarshall Wace LLPSold 35,323 shares on 8/14/2024Ownership: 0.047%Pete O'heeronBought 8,500 shares on 8/12/2024Total: $16,235.00 ($1.91/share)Hamid KhojaBought 10,000 shares on 8/12/2024Total: $19,000.00 ($1.90/share)Mercer Global Advisors Inc. ADVBought 10,272 shares on 8/12/2024Ownership: 0.029%Fund Evaluation Group LLCBought 1,055,105 shares on 8/6/2024Ownership: 2.954%View All Insider TransactionsView All Institutional Transactions FBLG Stock Analysis - Frequently Asked Questions How have FBLG shares performed this year? FibroBiologics' stock was trading at $17.75 at the beginning of the year. Since then, FBLG stock has decreased by 88.2% and is now trading at $2.09. View the best growth stocks for 2024 here. When did FibroBiologics IPO? FibroBiologics (FBLG) raised $144 million in an initial public offering on Wednesday, January 31st 2024. The company issued 4,806,226 shares at $30.00 per share. When did the company's lock-up period expire? FibroBiologics' lock-up period expired on Monday, July 29th. FibroBiologics had issued 4,806,226 shares in its public offering on January 31st. The total size of the offering was $144,186,780 based on an initial share price of $30.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period. Who are FibroBiologics' major shareholders? FibroBiologics' top institutional investors include Fund Evaluation Group LLC (2.95%), Cascade Financial Partners LLC (0.88%), Transform Wealth LLC (0.37%) and Bank of New York Mellon Corp (0.19%). View institutional ownership trends. How do I buy shares of FibroBiologics? Shares of FBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FBLG) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FBLG Stock Alerts